• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴比妥类药物与大鼠脑内腺苷受体的相互作用。

Interaction of barbiturates with adenosine receptors in rat brain.

作者信息

Lohse M J, Lenschow V, Schwabe U

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):69-74. doi: 10.1007/BF00518781.

DOI:10.1007/BF00518781
PMID:6089000
Abstract

The effects of barbiturates on radioligand binding to inhibitory Ri adenosine receptors of rat brain membranes were investigated. Binding of the adenosine receptor agonist (-)N6-phenylisopropyl[3H]adenosine and the antagonist 1,3-diethyl-8-[3H]phenylxanthine was inhibited by several barbiturates. This inhibition was concentration-dependent and occurred in the range of pharmacologically effective concentrations. Pentobarbital was the most potent of the barbiturates tested with a Ki of 92 mumol/l. The (+)isomers of hexobarbital and mephobarbital were more potent than the respective (-)isomers. Barbituric acid itself did not displace either radioligand in concentrations up to 1 mmol/l. The inhibitory effect of pentobarbital was reversed by a single wash of membranes preincubated with the barbiturate. The presence of pentobarbital caused a decrease of the affinity of the receptor for the antagonist radioligand but did not alter the number of binding sites, suggesting a competitive antagonism. The effects of pentobarbital on radioligand binding to the receptor were not changed by the presence of picrotoxinin nor by the absence of chloride ions. This indicates that they are not mediated via the picrotoxinin binding site. The barbiturates could not be classified as either agonists or antagonists at the Ri adenosine receptor. The presence of GTP did not influence the inhibition of radioligand binding by pentobarbital; this is also observed for antagonists, whereas the affinity of agonists is markedly reduced by GTP. Binding of antagonists to the receptor is enthalpy-driven; the interaction of pentobarbital with the receptor was entropy-driven and the same was true for agonists.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

研究了巴比妥类药物对放射性配体与大鼠脑膜抑制性 Ri 腺苷受体结合的影响。几种巴比妥类药物抑制了腺苷受体激动剂(-)N6-苯异丙基[3H]腺苷和拮抗剂 1,3-二乙基-8-[3H]苯基黄嘌呤的结合。这种抑制作用呈浓度依赖性,且发生在药理有效浓度范围内。戊巴比妥是所测试的巴比妥类药物中最有效的,其 Ki 为 92 μmol/l。己巴比妥和甲丙氨酯的(+)异构体比各自的(-)异构体更有效。巴比妥酸本身在浓度高达 1 mmol/l 时不会取代任何一种放射性配体。用巴比妥酸盐预孵育的膜经单次洗涤后,戊巴比妥的抑制作用可逆转。戊巴比妥的存在导致受体对拮抗剂放射性配体的亲和力降低,但不改变结合位点的数量,提示存在竞争性拮抗作用。戊巴比妥对放射性配体与受体结合的影响不受苦味毒存在与否或氯离子缺失的影响。这表明它们不是通过苦味毒结合位点介导的。巴比妥类药物在 Ri 腺苷受体上既不能归类为激动剂也不能归类为拮抗剂。GTP 的存在不影响戊巴比妥对放射性配体结合的抑制作用;拮抗剂也观察到这种情况,而激动剂的亲和力会被 GTP 显著降低。拮抗剂与受体的结合是由焓驱动的;戊巴比妥与受体的相互作用是由熵驱动的,激动剂也是如此。(摘要截短至 250 字)

相似文献

1
Interaction of barbiturates with adenosine receptors in rat brain.巴比妥类药物与大鼠脑内腺苷受体的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):69-74. doi: 10.1007/BF00518781.
2
Two affinity states of Ri adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding.脑膜中Ri腺苷受体的两种亲和状态。鸟嘌呤核苷酸和温度对放射性配体结合影响的分析。
Mol Pharmacol. 1984 Jul;26(1):1-9.
3
Guanine nucleotide and cation regulation of radioligand binding to Ri adenosine receptors of rat fat cells.鸟嘌呤核苷酸和阳离子对放射性配体与大鼠脂肪细胞Ri腺苷受体结合的调节作用
Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(3):241-7. doi: 10.1007/BF00505325.
4
Effects of N-ethylmaleimide on adenosine receptors of rat fat cells and human platelets.N-乙基马来酰亚胺对大鼠脂肪细胞和人血小板腺苷受体的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Sep;327(3):247-53. doi: 10.1007/BF00502457.
5
Barbiturates are selective antagonists at A1 adenosine receptors.巴比妥类药物是A1腺苷受体的选择性拮抗剂。
J Neurochem. 1985 Dec;45(6):1761-70. doi: 10.1111/j.1471-4159.1985.tb10532.x.
6
[3H]xanthine amine congener of 1,3-dipropyl-8-phenylxanthine: an antagonist radioligand for adenosine receptors.1,3 - 二丙基 - 8 - 苯基黄嘌呤的[3H]黄嘌呤胺类似物:一种腺苷受体拮抗剂放射性配体。
Proc Natl Acad Sci U S A. 1986 Jun;83(11):4089-93. doi: 10.1073/pnas.83.11.4089.
7
Differential binding properties of adenosine receptor agonists and antagonists in brain.脑内腺苷受体激动剂和拮抗剂的差异结合特性
J Neurochem. 1983 Aug;41(2):367-74. doi: 10.1111/j.1471-4159.1983.tb04752.x.
8
Characterization of the solubilized A1 adenosine receptor from rat brain membranes.大鼠脑膜中可溶性A1腺苷受体的特性分析。
J Neurochem. 1986 May;46(5):1528-34. doi: 10.1111/j.1471-4159.1986.tb01772.x.
9
Differential effects of sedative and anticonvulsant barbiturates on specific [3H]GABA binding to membrane preparations from rat brain cortex.镇静性和抗惊厥性巴比妥类药物对大鼠大脑皮层膜制剂中特定[3H]GABA结合的不同影响。
Biochem Pharmacol. 1982 Sep 15;31(18):2891-5. doi: 10.1016/0006-2952(82)90260-x.
10
Regional differences in the effect of guanine nucleotides on agonist and antagonist binding to adenosine A1-receptors in rat brain, as revealed by autoradiography.通过放射自显影术揭示鸟嘌呤核苷酸对大鼠脑中激动剂和拮抗剂与腺苷A1受体结合作用的区域差异。
Neuroscience. 1990;34(3):759-69. doi: 10.1016/0306-4522(90)90180-c.

引用本文的文献

1
AI-based identification of therapeutic agents targeting GPCRs: introducing ligand type classifiers and systems biology.基于人工智能的靶向G蛋白偶联受体的治疗药物鉴定:引入配体类型分类器和系统生物学
Chem Sci. 2023 Jul 24;14(32):8651-8661. doi: 10.1039/d3sc02352d. eCollection 2023 Aug 16.
2
C3 amino-substituted chalcone derivative with selective adenosine A receptor affinity in the micromolar range.具有微摩尔范围内选择性腺苷 A 受体亲和力的 C3 氨基取代查尔酮衍生物。
Chem Zvesti. 2021;75(4):1581-1605. doi: 10.1007/s11696-020-01414-9. Epub 2020 Nov 17.
3
Selective attenuation of norepinephrine release and stress-induced heart rate increase by partial adenosine A1 agonism.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Phenobarbital selectively modulates the glucagon-stimulated activity of adenylate cyclase by depressing the lipid phase separation occurring in the outer half of the bilayer of liver plasma membranes.苯巴比妥通过抑制肝细胞膜双层外半部分发生的脂质相分离,选择性地调节胰高血糖素刺激的腺苷酸环化酶活性。
Biochem J. 1981 Sep 1;197(3):675-81. doi: 10.1042/bj1970675.
3
Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
部分腺苷 A1 激动剂选择性抑制去甲肾上腺素释放和应激引起的心率增加。
PLoS One. 2011 Mar 28;6(3):e18048. doi: 10.1371/journal.pone.0018048.
4
The effects of temperature on the interactions between volatile general anaesthetics and a neuronal nicotinic acetylcholine receptor.温度对挥发性全身麻醉药与神经元烟碱型乙酰胆碱受体之间相互作用的影响。
Br J Pharmacol. 1995 Dec;116(7):2949-56. doi: 10.1111/j.1476-5381.1995.tb15949.x.
5
Assessment of the enantiomeric purity of R- and S-N6-phenylisopropyladenosine (PIA): implications for adenosine receptor subclassification.R-和S-N6-苯基异丙基腺苷(PIA)对映体纯度的评估:对腺苷受体亚分类的影响
Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):109-12. doi: 10.1007/BF00180020.
6
The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist.ZM 241385的体外药理学,一种强效、非黄嘌呤类A2a选择性腺苷受体拮抗剂。
Br J Pharmacol. 1995 Jul;115(6):1096-102. doi: 10.1111/j.1476-5381.1995.tb15923.x.
7
Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.
Psychopharmacology (Berl). 1987;93(4):428-34. doi: 10.1007/BF00207230.
8
Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors.非黄嘌呤杂环:作为A1和A2腺苷受体拮抗剂的活性。
Biochem Pharmacol. 1988 Feb 15;37(4):655-64. doi: 10.1016/0006-2952(88)90139-6.
9
Affinities of barbiturates for the GABA-receptor complex and A1 adenosine receptors: a possible explanation of their excitatory effects.
Naunyn Schmiedebergs Arch Pharmacol. 1987 Aug;336(2):211-7. doi: 10.1007/BF00165807.
10
Comparison of A1 adenosine receptors in brain from different species by radioligand binding and photoaffinity labelling.
Naunyn Schmiedebergs Arch Pharmacol. 1991 Feb;343(2):196-201. doi: 10.1007/BF00168610.
一种用于药理学受体亚型混合物放射性配体结合数据定量分析的计算机建模方法的验证与统计分析
Mol Pharmacol. 1982 Jan;21(1):5-16.
4
Barbiturate competition for TRH receptors in mouse brain: neuromodulation of anesthesia.巴比妥类药物对小鼠大脑中促甲状腺激素释放激素受体的竞争:麻醉的神经调节作用
Peptides. 1983 Mar-Apr;4(2):255-60. doi: 10.1016/0196-9781(83)90123-7.
5
Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations.A1 型腺苷受体对脑腺苷酸环化酶的抑制作用:药理学特性与定位
Brain Res. 1983 May 9;267(1):123-9. doi: 10.1016/0006-8993(83)91045-4.
6
Heterogeneity of adenosine A1 receptor binding in brain tissue.脑组织中腺苷A1受体结合的异质性。
Mol Pharmacol. 1982 Sep;22(2):250-7.
7
Guanine nucleotide and cation regulation of the binding of [3H]cyclohexyladenosine and [3H]diethylphenylxanthine to adenosine A1 receptors in brain membranes.鸟嘌呤核苷酸和阳离子对[3H]环己基腺苷及[3H]二乙苯基黄嘌呤与脑膜中腺苷A1受体结合的调节作用
Mol Pharmacol. 1982 Mar;21(2):329-35.
8
Drug interactions at the GABA receptor-ionophore complex.γ-氨基丁酸(GABA)受体-离子载体复合物处的药物相互作用。
Annu Rev Pharmacol Toxicol. 1982;22:245-77. doi: 10.1146/annurev.pa.22.040182.001333.
9
Adenosine receptors and behavioral actions of methylxanthines.腺苷受体与甲基黄嘌呤的行为作用
Proc Natl Acad Sci U S A. 1981 May;78(5):3260-4. doi: 10.1073/pnas.78.5.3260.
10
Mechanism of action of barbiturates.巴比妥类药物的作用机制。
Annu Rev Pharmacol Toxicol. 1981;21:83-111. doi: 10.1146/annurev.pa.21.040181.000503.